Series B life sciences investors
64 of 77 series b life sciences firms that report a preference say they can lead. 3 active since September.
Can leadMostly followsNot reportedRecently active
Arch Venture PartnersActive Sep 28
Paul Berns, Keith Crandell+12 on the team
Hitachi VenturesActive Oct 15
Pete Bastien, Stefan Gabriel+19 on the team
Safar PartnersActive Oct 13
Arunas Chesonis, Nader Motamedy+6 on the team
Anders Hove, Isaac Manke+2 on the team
Joel S. Marcus, Blake L. Stevens+2 on the team
Bob More, Dan Janney+1 on the team
Dave Maki, Kristen Wong
Dion Madsen, Jean-Francois Pariseau+7 on the team
Ken Horne, Ari Nowacek+9 on the team
David Michael, David Seldin+9 on the team
Seth L. Harrison, Anna Batarina+1 on the team
Dan Kidle, Jan Garfinkle+6 on the team
Christopher Male, Lauren Ingram+3 on the team
Behzad Aghazadeh, Mark Chin+2 on the team
Rob Carlson
Karan Wadhera, Yoni Meyer+1 on the team
George C. Petrocheilos, R. Jacob Vogelstein, Ph.D.+18 on the team
Aryeh Ganz, Jinny Choi+2 on the team
David Fallace, J.D. / M.B.A., Lou Tartaglia, Ph.D.+13 on the team
Nan Li, Zavain Dar+3 on the team
John H. Friedman, Kresimir Letinic+1 on the team
Stephen Knight, Amber Cai+17 on the team
Hyung Chun, MD, Shannon Bergstedt+11 on the team
Bruce Roberts, Lisa Wisniewski+4 on the team
Christy Shaffer, Clay B. Thorp+6 on the team
David Kabakoff, Garheng Kong+13 on the team
Brian Halak, Eric Heil+6 on the team
Ibrahim Ajami, Ayman Alabdallah+4 on the team
Eric Bednarski, Kyle Dempsey+1 on the team
Jay Zaveri
Ron Hunt, Vijay Lathi
Nayan Gregory Parekh, Subhanu Saxena+2 on the team
Somu Subramaniam, Andrew Abrams+1 on the team
Francesco Draetta, Bernard Davitian+9 on the team
Gregory Wood
Check size not reportedCan lead
C. Scotland Stevens, Carl L. Gordon+7 on the team
Bobby Helmedag, Yuriy Onyskiv
Christopher Steed, E. Kenneth Pentimonti+8 on the team
Michael C. Diem, Anthony Barry+4 on the team
Peter Bisgaard, Rob Hopfner+3 on the team
Get series b life sciences investors every Monday
Only the firms on this list that show new activity. Unsubscribe in one click.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRelated lists
Series B investors604Seed life sciences investors186Series A life sciences investors167Series B healthtech investors128Pre-seed life sciences investors95Series B enterprise software investors82Series B fintech investors74Series B climate investors68Series B deep tech investors66Series B industrial investors51Series B dev tools and infra investors49Series B cybersecurity investors42
Questions
How many series b life sciences investors are there?
Mode VC tracks 91 firms on this list as of 2026-10-15. 3 have been active since September 2026.
What check size do series b life sciences investors write?
The most reported band is $10M to $30M, reported by 32 firms on this list.
Which series b life sciences investors lead rounds?
64 of 77 firms that report a preference say they can lead. Turn on "Leads rounds" to see only them.